Piper Sandler Cuts Amgen (NASDAQ:AMGN) Price Target to $328.00
Amgen (NASDAQ:AMGN – Free Report) had its price target decreased by Piper Sandler from $329.00 to $328.00 in a report released on Friday,Benzinga reports. Piper Sandler currently has an overweight rating on the medical research company’s stock. Other research analysts have also issued reports about the stock. Mizuho lifted their price target on shares of […]
Amgen (NASDAQ:AMGN – Free Report) had its price target decreased by Piper Sandler from $329.00 to $328.00 in a report released on Friday,Benzinga reports. Piper Sandler currently has an overweight rating on the medical research company’s stock. Other research analysts have also issued reports about the stock. Mizuho lifted their price target on shares of […]
